The Cancer Tumor Profiling Market was valued at USD 6.04 billion in 2025 and is projected to grow to USD 12 billion by 2035, registering a CAGR of 7.1% during the forecast period. This significant growth trajectory reflects the essential role of cancer tumor profiling in addressing the demand for personalized medicine, targeted therapies, and improved patient outcomes across the...